Literature DB >> 2450424

Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus.

B Gotoh1, T Sakaguchi, K Nishikawa, N M Inocencio, M Hamaguchi, T Toyoda, Y Nagai.   

Abstract

Antigenic variants of D26 strain of Newcastle disease virus (NDV) were selected with monoclonal antibodies directed to the three nonoverlapping antigenic sites on the hemagglutinin-neuraminidase (HN) protein, and their HN genes were sequenced to identify the amino acids important for the integrity of each site. Seven variants for site I, which is immunodominant and conserved among NDV strains, had a change of glutamic acid at position 347, mostly to lysine, and in a single case, to glycine. In the second group of two variants for site IV, a change of asparagine to aspartic acid was found at position 481. This resulted in elimination of the oligosaccharide attached to this asparagine residue of the parental virus. Together with the finding that the site IV was destroyed by treatment with endoglycosidase F, it was suggested that the oligosaccharide is important for maintaining the structure of site IV. The oligosaccharide appeared to contribute to exposing a nearby determinant by conferring hydrophilicity on it. A variant for site II had also a nonconservative mutation resulting in the change of glutamic acid to valine at position 495. The site I recognized by antibodies which inhibit neuraminidase activity with a small substrate neuraminlactose was located closer to the predicted sialic acid-binding site than to the other sites recognized by antibodies lacking the enzyme-inhibiting capacity. The sequence of the parental virus HN gene revealed that the HNo precursor for the HN protein is an extra-long protein whose C terminus is elongated by 45 amino acids, compared with the usual HN protein sequenced in parallel.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450424     DOI: 10.1016/0042-6822(88)90244-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition.

Authors:  R M Iorio; R J Syddall; J P Sheehan; M A Bratt; R L Glickman; A M Riel
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  Characterization of a recombinant Newcastle disease virus vaccine strain.

Authors:  Sun-Hee Cho; Hyuk-Joon Kwon; Tae-Eun Kim; Jae-Hong Kim; Han-Sang Yoo; Man-Hoon Park; Young-Ho Park; Sun-Joong Kim
Journal:  Clin Vaccine Immunol       Date:  2008-09-03

3.  Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization.

Authors:  T Toyoda; B Gotoh; T Sakaguchi; H Kida; Y Nagai
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

4.  Membrane glycoproteins of Newcastle disease virus: nucleotide sequence of the hemagglutinin-neuraminidase cloned gene and structure/function relationship of predicted amino acid sequence.

Authors:  A Sagrera; C Cobaleda; J M González De Buitrago; A García-Sastre; E Villar
Journal:  Glycoconj J       Date:  2001-04       Impact factor: 2.916

5.  A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus.

Authors:  T Shioda; S Oka; S Ida; K Nokihara; H Toriyoshi; S Mori; Y Takebe; S Kimura; K Shimada; Y Nagai
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Pathogenicity and phylogenetic evaluation of the variant Newcastle disease viruses termed "pigeon PMV-1 viruses" based on the nucleotide sequence of the fusion protein gene.

Authors:  M S Collins; I Strong; D J Alexander
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Comparison of Newcastle disease viruses isolated from cormorants in Canada and the USA in 1975, 1990 and 1992.

Authors:  R A Heckert; M S Collins; R J Manvell; I Strong; J E Pearson; D J Alexander
Journal:  Can J Vet Res       Date:  1996-01       Impact factor: 1.310

8.  Variation of a newcastle disease virus hemagglutinin-neuraminidase linear epitope.

Authors:  Sun-Hee Cho; Hyuk-Joon Kwon; Tae-Eun Kim; Jae-Hong Kim; Han-Sang Yoo; Sun-Joong Kim
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

9.  Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease viruses showing variation in antigenicity and pathogenicity.

Authors:  M S Collins; J B Bashiruddin; D J Alexander
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Antiviral action of interferon-beta on Newcastle disease virus: selectivity to the hemagglutinin-neuraminidase gene expression.

Authors:  Z Yu; B Gotoh; M Hamaguchi; Y Nagai
Journal:  Med Microbiol Immunol       Date:  1995-05       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.